已批准和商用菌体治疗药物的前景
1Institute for Technology Assessment and Systems Analysis (ITAS), Karlsruhe Institute of Technology, Karlsruhe, Germany.
International journal of antimicrobial agents
|September 8, 2025
概括
菌体 (菌体) 疗法显示出对抗抗生素耐药细菌的前景. 克服监管和经济障碍是批准的菌体治疗方法长期成功的关键.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗生素耐药性是一个日益增长的全球健康威胁.
- 菌体 (菌体) 治疗是一种新兴的抗生素替代品.
- 目前,没有菌体治疗药物获得营销许可,限制了它们的使用.
研究的目的:
- 分析商业生产和批准的菌体治疗方法的挑战和机遇.
- 评估专利和临床试验对菌体疗法的商业化影响.
主要方法:
- 审查目前的菌体疗法发展格局.
- 对专利申请和临床试验数据的分析.
- 审查监管和经济障碍.
主要成果:
- 生物技术公司的专利申请和菌体临床试验显著增加.
- 与临床证据和专利相关的挑战似乎是可以克服的.
- 批准后的监管和经济因素对于长期成功至关重要.
结论:
- 菌体治疗药物的商业化正在推进,随着研究和投资的增加.
- 政策解决方案对于解决批准后的监管和经济障碍至关重要.
- 菌体治疗的成功实施需要解决最初批准之外的系统性挑战.
相关概念视频
Lytic Cycle of Bacteriophages
77.5K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.5K
Microorganisms in Medicine and Therapeutics
989
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
989
DNA Bacteriophages
827
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
827
Lysogenic Cycle of Bacteriophages
67.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K


